NCT01860144 An Observational Study of Bevacizumab in Chinese Patients With Metastatic Colorectal Cancer Status UNKNOWN Phase N/A
NCT01858649 Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Bevacizumab With FOLFOX or FOLFIRI. Status COMPLETED Phase PHASE2
NCT01854593 Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy Status COMPLETED Phase PHASE4
NCT01852409 Phase I Trial of Intraperitoneal Bevacizumab in Refractory Malignant Ascites Status UNKNOWN Phase PHASE1
NCT01847677 Neoadjuvant Therapy in Advanced Ovarian Cancer With Avastin Status TERMINATED Phase PHASE2
NCT01838538 Clinical Study in Treatment of Malignant Ascites of Ovarian Cancer With Intraperitoneal Injection Bevacizumab Combined With Intraperitoneal Hyperthermic Perfusion Chemotherapy Status UNKNOWN Phase PHASE2
NCT01837862 A Phase I Study of Mebendazole for the Treatment of Pediatric Gliomas Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT01837251 Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer Status COMPLETED Phase PHASE3
NCT01836653 Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases Status COMPLETED Phase PHASE2
NCT01834014 Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases Status COMPLETED Phase NA
NCT01818973 Preoporative Bevacizumab, Radiation Therapy, and XELOX Chemotherapy for Locally Advanced Nonmetastatic Rectal Cancer Status UNKNOWN Phase PHASE2
NCT01814813 Vaccine Therapy With Bevacizumab Versus Bevacizumab Alone in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery Status TERMINATED Phase PHASE2
NCT01811498 Repeated Super-Selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Newly Diagnosed GBM Status COMPLETED Phase PHASE1/PHASE2
NCT01803282 Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01802749 Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer Status UNKNOWN Phase PHASE3
NCT01802645 Cetuximab/FOLFIRI With or Without Oxaliplatin and FOLFOXIRI With or Without Bevacizumab in Neoadjuvant Treatment of Non-resectable Colorectal Liver Metastases Status UNKNOWN Phase PHASE2
NCT01792934 Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases Status ACTIVE_NOT_RECRUITING Phase NA
NCT01782976 Ph II Cilengitide Plus Bevacizumab for Recurrent Glioblastoma (GBM) Status WITHDRAWN Phase PHASE2